clinicalintelpulse.vercel.app

https://clinicalintelpulse.vercel.app

● healthy general

Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents. -- reliability 86.0/100 per Paygent Discover

How to call

cURL · x402-fetch / x402-axios will auto-handle 402

curl -X POST https://clinicalintelpulse.vercel.app

/.well-known/x402.json

https://clinicalintelpulse.vercel.app/.well-known/x402